DSV has expanded its Air ThermoDirect offering by establishing a new direct air freight connection between Luxembourg and Indianapolis. This strategic move is designed to bolster temperature-controlled supply chains for pharmaceutical products. The new route will utilize Indianapolis International Airport, which is recognized as a rapidly expanding center for life sciences and healthcare logistics within the United States.
This initiative by DSV aims to improve cold-chain connectivity, providing specialized solutions for the transport of sensitive pharmaceutical cargo. For freight forwarders and operations managers, this new direct service means enhanced capacity and potentially more reliable transit times for temperature-sensitive pharma shipments between Europe and the US Midwest. It offers a dedicated, controlled environment, which can mitigate risks associated with transshipment or less specialized routes, thereby improving supply chain integrity for pharmaceutical clients. This could lead to more competitive service offerings for forwarders handling pharma logistics on this specific trade lane.
The expansion reinforces DSV's commitment to the pharmaceutical logistics sector, addressing the critical need for secure and compliant cold-chain solutions in a global market.
